Early breast cancer: Adjuvant chemotherapy or radiotherapy, or both?

References

• Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet 2005;365:1687–717.
   PubMed Web of Science ®Google Scholar
• Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 2005;366:2087–106.
   PubMed Web of Science ®Google Scholar
• Arriagada R, Rutqvist LE, Mattsson A, Kramar A, Rotstein S. Adequate locoregional treatment for early breast cancer may prevent secondary dissemination. J Clin Oncol 1995; 13: 2869–78
   PubMed Web of Science ®Google Scholar
• Rutqvist LE, Johansson H, on behalf of the Stockholm Breast Cancer Study Group. Long-term follow-up of the Stockholm randomized trials of postoperative radiation therapy versus adjuvant chemotherapy among “high risk” pre- and postmenopausal breast cancer patients. Acta Oncol 2006;45:517–527.
   PubMed Web of Science ®Google Scholar
• Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutical trials. J Chronic Dis 1967; 20: 637–48
   PubMedGoogle Scholar
• Bonadonna G, Valagussa P, Moliterni A, Zambetti M, Brambilla C. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer-The results of 20 years of follow-up. N Engl J Med 1995; 332: 901–6
   PubMed Web of Science ®Google Scholar
• Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. N Engl J Med 1995;333:1444–55.
   PubMed Web of Science ®Google Scholar
• Arriagada R, Rutqvist LE. Adjuvant chemotherapy in early breast cancer and incidence of new primary malignancies. Lancet 1991; 338: 535–8
   PubMed Web of Science ®Google Scholar
• Roychoudhuri R, Evans H, Robinson D, Moller H. Radiation-induced malignancies following radiotherapy for breast cancer. Br J Cancer 2004; 91: 868–72
   PubMed Web of Science ®Google Scholar
• Darby SC, McGale P, Taylor CW, Peto R. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: Prospective cohort study of about 300 000 women in US SEER registries. Lancet 2005; 6: 557–65
   Google Scholar
• Rubino C, De Vathaire F, Shamsaldin A, Labbé M, Lê MG. Radiation dose, chemotherapy, hormonal treatment and risk of second cancer after breast cancer treatment. Br J Cancer 2003; 89: 840–6
   PubMed Web of Science ®Google Scholar
• Poortmans P, Kouloulias VE, Venselaar JL, Struikmans H, Davis JB, Huyskens D, et al. Quality assurance of EORTC trial 22922/10925 investigating the role of internal mammary-medial supraclavicular irradiation in stage I-III breast cancer: the individual case review. Eur J Cancer 2003; 39: 2035–42
   PubMed Web of Science ®Google Scholar
• Björk-Eriksson T, Glimelius B. The potential of proton beam therapy in breast cancer. Acta Oncol 2005; 44: 884–9
   PubMed Web of Science ®Google Scholar
• Hall EJ, Wuu CS. Radiation-induced second cancers: The impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 2003; 56: 83–8
   PubMed Web of Science ®Google Scholar
• Dewar JA, Sarrazin D, Benhamou S, Petit JY, Benhamou E, Arriagada R, et al. Management of the axilla in conservatively-treated breast cancer: 592 patients treated at the Institut Gustave-Roussy. Int J Radiat Oncol Biol Phys 1987; 13: 475–81
   PubMed Web of Science ®Google Scholar
• Rubino C, Shamsaldin A, Lê MG, Labbé M, Guinebretière JM, Chavaudra J, et al. Radiation dose and risk of soft tissue and bone sarcoma after breast cancer treatment. Breast Cancer Res Treat 2005; 89: 277–88
   PubMed Web of Science ®Google Scholar
• Prochazka M, Hall P, Gagliardi G, Granath F, Nilsson BN, Shields PG, et al. Ionizing radiation and tobacco use increases the risk of a subsequent lung carcinoma in women with breast cancer: Case-only design. J Clin Oncol 2005; 23: 7467–74
   PubMed Web of Science ®Google Scholar
• Arriagada R, Spielmann M, Kocielny S, Le Chevalier T, Delozier T, Rémé-Saumon M, et al. Results of two randomized trials evaluating adjuvant anthracycline- based chemotherapy in 1,146 patients with early breast cancer. Acta Oncol 2005; 44: 458–66
   PubMed Web of Science ®Google Scholar